KANZEN R&D
leading healthy beauty
The Kanzen R&D Research Center of Kanzen,
a global bio company, is the starting point of
Kanzen Cosmedical and studies
safer and more reliable next-generation
core technologies.
Through continuous research on botulinum toxin,
we developed TBT-A1 technology using
CDP technology to provide
only high-quality products which
have been proven medically.
With differentiated botulinum raw materials
and a different level of skin care technology,
we lead the true cosmedical market
Through the development of raw materials,
quality control, and better technology.
Kanzen R&D Network
leading healthy beauty
-
View of Seoul National University's
Biotechnology Research Building -
Inside the Headquarters Research Center
(3rd floor of the Biotechnology Research Building)
Co - Partner
bio research institutes
-
ABL3
Animal Lab -
Veterinary Science
Research Center -
Next-generation immunotherapy Basic development
-
Bioinformatics
Research Center
Kanzen Network
advanced technology research
Seven types of botulinum toxin isolated from
domestic soil are unique strains isolated with
Kanzen's proprietary technology,
and they are the competitiveness in
making differentiated products.
Research to secure the largest number of
botulinum strains in the world is ongoing.
Business Registration No : 683-88-00195
E-commerce Permit : 2017-Seoul Gwanak_0869
Address : 08826) 1, Gwanak-ro, Gwanak-gu, Seoul (Silrim-dong) Seoul National University Biotechnology Joint Research Building 220, 6th floor, Room 639
Copyrightⓒ 2022 kanzen, ALL right reserved.
02-876-4633
Closed on Saturdays,
Sundays and public holidays
